Therapeutic strategies to slow down or halt the progression of NAFLD consist mainly of lifestyle changes (diet, smoke/alcohol cessation, and physical activity) with the aim of reducing body weight and visceral adiposity, improving insulin sensitivity, and reducing cardiometabolic risk factors [21, 22]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.